Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003763 · ClinicalTrials.gov registry record · NA
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
A NA study, sponsored by Endocyte.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00003763: Completed NA study, sponsored by Endocyte.
NCT00003763 is a NA study that has completed, run by Endocyte. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003763, a NA study, has completed, sponsored by Endocyte.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.
Interventions
- PROCEDURE radionuclide imaging
- RADIATION indium In 111 folic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 1997-12-08 |
| Est. Completion | 2000-05-03 |
| Phase | NA |
What the finished NCT00003763 record still lists
NCT00003763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which radionuclide imaging is the first listed.
NCT00003763 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003763 about?
NCT00003763 is a clinical study titled "Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer". RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.
What is the current status of trial NCT00003763?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 1997-12-08. Estimated completion is 2000-05-03.
What interventions are being tested in trial NCT00003763?
The interventions under investigation include: radionuclide imaging (PROCEDURE), indium In 111 folic acid (RADIATION).
Who is sponsoring clinical trial NCT00003763?
This trial is sponsored by Endocyte, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00003763's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI